Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is ...
Feb 27, 2013
0
0
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published ...
Dec 6, 2012
0
0
Combining a new targeted therapy with standard chemotherapy may help defeat pancreatic cancer, according to results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, ...
Jun 19, 2012
0
0
Johns Hopkins investigators are testing a way to use drugs that target a cholesterol pathway to enhance the cancer-killing potential of standard chemotherapy drugs. Their tests, in mouse models of pancreatic cancer, may yield ...
Apr 3, 2012
0
0
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of resistance for new drugs ...
Mar 19, 2012
0
0
Erxi Wu, assistant professor of pharmaceutical sciences, co-wrote the review article, “The paracrine Sonic Hedgehog signaling derived from tumor epithelial cells: A key regulator in the pancreatic tumor microenvironment,” ...
Feb 17, 2012
0
0
